177 related articles for article (PubMed ID: 26571391)
1. Memory or amnesia: the dilemma of stem cell therapy in muscular dystrophies.
Sandri M
J Clin Invest; 2015 Dec; 125(12):4331-3. PubMed ID: 26571391
[TBL] [Abstract][Full Text] [Related]
2. Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle.
Quattrocelli M; Swinnen M; Giacomazzi G; Camps J; Barthélemy I; Ceccarelli G; Caluwé E; Grosemans H; Thorrez L; Pelizzo G; Muijtjens M; Verfaillie CM; Blot S; Janssens S; Sampaolesi M
J Clin Invest; 2015 Dec; 125(12):4463-82. PubMed ID: 26571398
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitors.
Giacomazzi G; Holvoet B; Trenson S; Caluwé E; Kravic B; Grosemans H; Cortés-Calabuig Á; Deroose CM; Huylebroeck D; Hashemolhosseini S; Janssens S; McNally E; Quattrocelli M; Sampaolesi M
Nat Commun; 2017 Nov; 8(1):1249. PubMed ID: 29093487
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid stimulates myogenesis in pluripotent stem cell-derived mesodermal progenitors in a NOTCH-dependent manner.
Breuls N; Giarratana N; Yedigaryan L; Garrido GM; Carai P; Heymans S; Ranga A; Deroose C; Sampaolesi M
Cell Death Dis; 2021 Jul; 12(7):677. PubMed ID: 34226515
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic cell memory reinforces myogenic commitment of pericyte-derived iPSCs.
Quattrocelli M; Palazzolo G; Floris G; Schöffski P; Anastasia L; Orlacchio A; Vandendriessche T; Chuah MK; Cossu G; Verfaillie C; Sampaolesi M
J Pathol; 2011 Apr; 223(5):593-603. PubMed ID: 21341275
[TBL] [Abstract][Full Text] [Related]
6. Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy.
Sun C; Serra C; Kalicharan BH; Harding J; Rao M
Cells; 2024 Mar; 13(7):. PubMed ID: 38607035
[TBL] [Abstract][Full Text] [Related]
7. An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells.
Filareto A; Parker S; Darabi R; Borges L; Iacovino M; Schaaf T; Mayerhofer T; Chamberlain JS; Ervasti JM; McIvor RS; Kyba M; Perlingeiro RC
Nat Commun; 2013; 4():1549. PubMed ID: 23462992
[TBL] [Abstract][Full Text] [Related]
8. Myogenic Progenitors from Mouse Pluripotent Stem Cells for Muscle Regeneration.
Magli A; Incitti T; Perlingeiro RC
Methods Mol Biol; 2016; 1460():191-208. PubMed ID: 27492174
[TBL] [Abstract][Full Text] [Related]
9. Generation of human myogenic progenitors from pluripotent stem cells for in vivo regeneration.
Kim H; Perlingeiro RCR
Cell Mol Life Sci; 2022 Jul; 79(8):406. PubMed ID: 35802202
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice.
Bittner RE; Schöfer C; Weipoltshammer K; Ivanova S; Streubel B; Hauser E; Freilinger M; Höger H; Elbe-Bürger A; Wachtler F
Anat Embryol (Berl); 1999 May; 199(5):391-6. PubMed ID: 10221450
[TBL] [Abstract][Full Text] [Related]
11. Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies.
Selvaraj S; Kyba M; Perlingeiro RCR
Trends Mol Med; 2019 Sep; 25(9):803-816. PubMed ID: 31473142
[TBL] [Abstract][Full Text] [Related]
12. Stem cell therapy for muscular dystrophies.
Biressi S; Filareto A; Rando TA
J Clin Invest; 2020 Nov; 130(11):5652-5664. PubMed ID: 32946430
[TBL] [Abstract][Full Text] [Related]
13. Generation of craniofacial myogenic progenitor cells from human induced pluripotent stem cells for skeletal muscle tissue regeneration.
Kim E; Wu F; Wu X; Choo HJ
Biomaterials; 2020 Jul; 248():119995. PubMed ID: 32283390
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR).
Elhussieny A; Nogami K; Sakai-Takemura F; Maruyama Y; Takemura N; Soliman WT; Takeda S; Miyagoe-Suzuki Y
Stem Cell Res Ther; 2021 Oct; 12(1):532. PubMed ID: 34627382
[TBL] [Abstract][Full Text] [Related]
15. Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering.
Maffioletti SM; Sarcar S; Henderson ABH; Mannhardt I; Pinton L; Moyle LA; Steele-Stallard H; Cappellari O; Wells KE; Ferrari G; Mitchell JS; Tyzack GE; Kotiadis VN; Khedr M; Ragazzi M; Wang W; Duchen MR; Patani R; Zammit PS; Wells DJ; Eschenhagen T; Tedesco FS
Cell Rep; 2018 Apr; 23(3):899-908. PubMed ID: 29669293
[TBL] [Abstract][Full Text] [Related]
16. Stem cell therapies to treat muscular dystrophy: progress to date.
Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of induced pluripotent stem cell-derived mesoangioblast-like myogenic progenitors in mouse models of muscle regeneration.
Gerli MF; Maffioletti SM; Millet Q; Tedesco FS
J Vis Exp; 2014 Jan; (83):e50532. PubMed ID: 24472871
[TBL] [Abstract][Full Text] [Related]
18. Establishment of Skeletal Myogenic Progenitors from Non-Human Primate Induced Pluripotent Stem Cells.
Baik J; Ortiz-Cordero C; Magli A; Azzag K; Crist SB; Yamashita A; Kiley J; Selvaraj S; Mondragon-Gonzalez R; Perrin E; Maufort JP; Janecek JL; Lee RM; Stone LH; Rangarajan P; Ramachandran S; Graham ML; Perlingeiro RCR
Cells; 2023 Apr; 12(8):. PubMed ID: 37190056
[TBL] [Abstract][Full Text] [Related]
19. Generation of Equine-Induced Pluripotent Stem Cells and Analysis of Their Therapeutic Potential for Muscle Injuries.
Lee EM; Kim AY; Lee EJ; Park JK; Park SI; Cho SG; Kim HK; Kim SY; Jeong KS
Cell Transplant; 2016 Nov; 25(11):2003-2016. PubMed ID: 27226077
[TBL] [Abstract][Full Text] [Related]
20. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
